The Medicare Drug Payment Model Worsens a Bad Situation

According to the American Society of Clinical Oncology (ASCO), the proposal by the Centers for Medicare & Medicaid Services that will change the way Medicare pays for drugs under Part B program could/will hurt oncologists.

ASCO states that oncologists do not receive enough reimbursement from Medicare on many cancer drugs to cover the cost of acquire them.   They believe this is a misguided attempt to control the high cost of drugs by putting the burden on the backs of the providers. Read the article here……


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or